M-Power Tampa Community Event On Health Empowerment.

Focusing on awareness of multiple myeloma in the African American community and living a healthier life.

The M-Power Project realizes the IMF Diversity Initiative's vision, enhancing outcomes for African-American myeloma patients. Though the most common blood cancer in this group, with reduced barriers to diagnosis and treatment, they fare as well as or even better than white individuals. Empowering healthcare professionals, community leaders, neighborhoods, and families, M-Power raises myeloma awareness.

Watch Recordings From the Event:

Opening Remarks: Changing the Course of Myeloma in the Black Community

Dr. Joseph Mikhael, Chief Medical Officer of the International Myeloma Foundation, provided an informative overview of myeloma during an M-Power Community Workshop in Tampa. Myeloma, a blood cancer, originates in the bone marrow and primarily affects plasma cells responsible for producing antibodies. Patients with myeloma often experience fatigue, pain, and anemia. Dr. Mikhael highlighted the significant advancements in myeloma treatments, including various drug classes, immunomodulatory drugs, and innovative therapies such as CAR T-cell therapy. The M-Power program strives to change the course of myeloma in the African-American community.

Addressing Disparities: Race Matters in Myeloma Care and Survival

International Myeloma Foundation Chief Medical Officer Dr. Joseph Mikhael discusses the critical issue of racial disparities in myeloma care and survival. In this recording, we explore why race matters in myeloma and how it affects the course of the disease. Dr. Joseph Mikhael, a leading expert in the field, presents the top 10 facts about myeloma, highlighting the challenges faced by African-American patients.

Learn about the importance of early diagnosis, access to diagnostics, and the role of primary care doctors in recognizing myeloma symptoms. Discover the disparities in treatment options and the impact of clinical trials on different racial communities. Dr. Mikhael shares insights into biological differences in myeloma and presents encouraging data from the VA system.

An Interview with Dr. Brandon Blue "Giving Back to My Community"

In this presentation, Dr. Brandon Blue shares his journey from growing up in St. Petersburg, Florida, to becoming a medical doctor specializing in multiple myeloma. He discusses his experiences, his decision to focus on oncology, and his mission to help the community. Dr. Blue emphasizes the importance of serving not only the physical but also the spiritual and mental needs of patients. He also touches on the disparities in cancer care and the significance of addressing them.

The Importance of Communication in the Context of Multiple Myeloma Care.

Beth Finley Oliver, MSN, ARNP, AGNP-BC emphasizes the importance of communication in the context of multiple myeloma care. She discusses various aspects, including the role of nurses in managing side effects, educating patients, and offering support. She also touches on the significance of knowing your disease type and treatment plan, seeking co-pay assistance for financial burdens, and addressing symptoms and side effects with the medical team. She highlights the value of being an active participant in your healthcare, seeking information, and reaching out to available resources to navigate the disease effectively.

Cancer Prevention, Community Care, Innovative Research

Join Dr. Brandon Blue in this insightful discussion about the mission of Moffitt Cancer Center, focusing on cancer prevention, community engagement, and cutting-edge research. Learn about the "Cancer in Our Community" podcast, Moffitt's involvement in various health initiatives, and its commitment to taking care of Florida residents. Discover how Moffitt aims to connect the pieces of the cancer puzzle and promote early screenings. 

Myeloma Clinical Trials: Part of the Treatment Journey

Clinical trials are vital for advancing myeloma treatments. In this informative discussion, the panelists provide insights into the importance of clinical trials, demystify common misconceptions, and stress the significance of open and honest communication with your healthcare team. Learn how clinical trials can provide you with more options and potentially improve your outcomes while ensuring that you are not alone in this journey

Patient and Care Partner Interview: Gary and Nadia Lambert's Inspiring Myeloma Journey

In this segment, we hear from Gary and Nadia Lambert, who share their story of battling myeloma. Discover their remarkable experiences, challenges, and triumphs in their fight against this disease. Learn about the importance of health literacy and the role of a supportive partner in the journey. Gain insights into managing myeloma treatment. Gary and Nadia Lambert's story is a testament to resilience, knowledge, and the power of teamwork in the face of myeloma.